台股 » 個股 » 易威 » 籌碼相關 » 券商分點績效 » 券商分點個股進出

易威

(1799)
  • 股價
    65.0
  • 漲跌
    ▼2.3
  • 漲幅
    -3.42%
  • 成交量
    434
  • 產業
    上櫃 生技醫療類股
  • 73人加入追蹤

    立即追蹤

  • 本地時間:13:30(已收盤)

     
易威 (1799)籌碼相關-群益金鼎-民權 券商分點個股進出
券商分點績效/獲利分析

透過統計各券商分點在長期買賣某個股的操作績效,來找出真正獲利的贏家所在券商分點,進而追蹤此贏家所操作的股票與軌跡。

群益金鼎-民權 券商分點個股進出

日期買進張數買進均價賣出張數賣出均價收盤價買賣超60日均量成交佔比 大量交易提示
2025/05/09166.4000.0065.0014950.20%
2025/05/0800.00167.5067.30-1491-0.20%
2025/05/0700.00166.2065.90-1481-0.21%
2025/05/05159.4000.0059.3014710.21%
2025/04/301060.6000.0059.60104702.12%
2025/04/28156.5000.0056.9014610.22%
2025/04/2200.00156.7055.50-1471-0.21%
2025/04/17159.4000.0058.6014890.20%
2025/03/20673.5000.0073.1065951.01%
2025/03/1700.000.578.0077.50-0.5616-0.08%
2025/03/14378.40182.2077.7026170.32%
2025/03/1300.00680.6781.00-6603-0.99%
2025/03/121178.9900.0077.50115851.88%
2025/03/1112.577.8300.0081.5012.55572.24%
2025/03/10571.5000.0076.8055180.96%
2025/03/07373.8000.0069.9034960.60%
2025/03/04268.80168.6069.6014830.21%
2025/03/03364.7000.0069.6034830.62%
2025/02/211069.3000.0067.80105081.97%
2025/02/20564.8400.0071.0054971.01%
2025/02/12163.6000.0061.9015850.17%
2025/02/05362.0000.0060.7036050.50%
2025/01/06264.3000.0065.1026230.32%
2024/12/271064.0700.0063.30106971.43%
2024/12/262069.87370.7066.60176922.45%
2024/12/252474.7100.0074.00246833.51%
2024/12/24370.0000.0073.0036770.44%
2024/12/20261.0000.0060.4026840.29%
2024/12/19563.1000.0062.7056950.72%
2024/12/1200.00156.0054.90-1678-0.15%
2024/12/11154.9000.0054.9016660.15%
2024/12/0900.00262.7562.00-2646-0.31%
2024/11/22270.30172.9073.0016720.15%
2024/11/20167.4000.0067.4016660.15%
2024/11/0800.00378.8377.80-3603-0.50%
2024/10/1100.001115.50114.50-1824-0.12%
2024/10/091115.002130.25119.00-1838-0.12%
2024/10/0700.0010114.35116.50-10830-1.20%
2024/10/04490.631106.50106.5038130.37%
2024/10/01699.7500.0097.2067870.76%
2024/09/303108.0000.00108.0037770.39%
2024/09/261133.0000.00133.0017850.13%
2024/09/251154.5000.00147.5017840.13%
2024/09/161175.5000.00175.5017800.13%
2024/09/101183.0000.00183.0018120.12%
2024/09/091188.0000.00195.0018080.12%
2024/09/061201.0000.00195.0018000.12%
2024/09/042209.5000.00207.0028020.25%
2024/09/0200.001227.00222.50-1798-0.13%
2024/08/281215.0000.00210.0017880.13%
2024/08/2700.000.1222.00220.00-0.1785-0.01%
2024/08/2200.000.1223.00221.50-0.1798-0.01%
2024/08/210.1226.501220.00225.00-0.9802-0.11%
2024/08/2000.001208.00216.00-1806-0.12%
2024/08/141187.0000.00192.0018410.12%
2024/08/131193.5000.00189.0018430.12%
2024/08/121201.0000.00198.0018350.12%
2024/08/091181.001205.50203.5008240.00%
2024/08/073174.6700.00180.0037810.38%
2024/08/0600.001172.00171.00-1777-0.13%
2024/08/0200.000.1180.98177.50-0.1749-0.01%
2024/07/311155.6700.00161.0017270.14%
2024/07/2900.001149.50141.50-1708-0.14%
2024/07/261149.260153.00148.0017000.14%
2024/07/2200.000165.00164.0006670.00%
2024/07/190.1185.251.2179.71182.00-1.2650-0.18%
2024/07/180.1196.3400.00196.500.16110.01%
2024/07/170.1190.7500.00191.000.15890.01%
2024/07/161174.500.2165.00174.500.85660.14%
2024/07/1500.000.9160.17164.50-0.9554-0.16%
2024/07/121.2161.4200.00162.001.25440.22%
2024/06/2800.001120.00130.00-1413-0.24%
2024/06/120.199.49196.5097.40-1327-0.29%
2024/06/111100.5000.00101.5013240.31%
2024/05/3100.000.692.5091.80-0.6317-0.18%
2024/05/3000.001.391.5090.90-1.3320-0.40%
2024/05/2300.002100.50100.50-2286-0.70%
2024/05/2000.000.385.5786.30-0.3238-0.13%
易威慢性心臟衰竭用藥獲中國藥證 明年Q1底展開銷售Anue鉅亨-2023/10/30
美新行政令強化製藥在地化 易威、泰福-KY迎來新訂單Anue鉅亨-2022/09/20
〈易威法說〉策略轉型見成效 新藥、學名藥營收比重拚達7成Anue鉅亨-2021/12/17
易威 相關文章
易威 相關影音